← Leaderboards
Warwick Britton
University Of Sydney
$10,964,476
Attributed
$10,964,476
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.6M · FY2022–25$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25
Funding mix
By agency
NIH$10,964,476 · 1
By mechanism
N01$10,964,476 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Sydney
Same institution · by research overlap
- Kim Chan$985,509
- Shaokoon Cheng$100,000
- Agisilaos Kourmatzis$100,000
- Runyu Yang$100,000
Others in their field
Other Rising Stars on “Vaccines”
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- Angee Greer · Ppd Development Lp$82,531,927
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Kevin Saunders · Duke University$18,106,404
- Daniel Hunter Reirden · Westat, Inc.$16,121,731
- Jason Dickens · Duke University$12,259,409
Research focus
VaccinesAerosolsAnimalsAntigensCause Of DeathCellsClinical CandidateClinical DevelopmentDoseEvaluationFormulationImmuneImmunityImmunologicsInbred MouseInfectious AgentIn VitroMacaca MulattaMouse ModelMycobacterium TuberculosisMycobacterium Tuberculosis AntigensNonhuman PrimateAdjuvantPersons
Grant awards (5)
Advancing Vaccine Adjuvant Research for Tuberculosis (TB)$2,000,000
N01 · FY2025 · AI · contact PI
ADVANCING VACCINE ADJUVANT RESEARCH FOR TUBERCULOSIS (AVAR-T)$2,091,723
N01 · FY2024 · AI · contact PI
Advancing Vaccine adjuvant Research for Tuberculosis (TB)$800,000
N01 · FY2024 · AI · contact PI
ADVANCING VACCINE ADJUVANT RESEARCH FOR TUBERCULOSIS (AVAR-T)$3,619,193
N01 · FY2023 · AI · contact PI
ADVANCING VACCINE ADJUVANT RESEARCH FOR TUBERCULOSIS (AVAR-T)$2,453,560
N01 · FY2022 · AI · contact PI